Director's Dealings
09/01/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240109:nRSI0173Za&default-theme=true
RNS Number : 0173Z Cellular Goods PLC 09 January 2024
The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014, as retained as part of the law of England and Wales. Upon
the publication of this announcement via the Regulatory Information Service,
this inside information is now considered to be in the public domain.
9 January 2024
Cellular Goods PLC
("Cellular Goods" or "The Company")
Director's Dealings
Cellular Goods (LSE: CBX), a UK-based company pioneering the use of lab-based
and biosynthetic production methods for wellness and sustainability solutions,
announces that Michael Edwards (Executive Director of Cellular Goods) has
purchased a total of 5,500,000 ordinary shares in the Company ("Ordinary
Shares"), the details of which are set out in the notification below.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Michael Edwards
2. Reason for the Notification
a) Position/status Executive Director
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cellular Goods PLC
b) LEI 213800IXPX4Z2MKX2U28
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares
Identification Code GB00BK964W87
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
0.325 pence per Ordinary Share 5,500,000 Ordinary Shares
d) Aggregated information:
· Aggregated volume 5,500,000 Ordinary Shares
· Price 0.325 pence per Ordinary Share
e) Date of the transaction 08 January 2024
f) Place of the Transaction London Stock Exchange
d)
Aggregated information:
· Aggregated volume
· Price
5,500,000 Ordinary Shares
0.325 pence per Ordinary Share
e)
Date of the transaction
08 January 2024
f)
Place of the Transaction
London Stock Exchange
For further information please contact:
Cellular Goods
Michael Edwards via FSCF +44 7572 873 300
Director
First Sentinel Corporate Finance (FSCF)
Investor Relations
Rebecca Noonan +44 7572 873 300
IR@cellular-goods.com (mailto:IR@cellular-goods.com)
Media Relations
Rebecca Noonan +44 7572 873 300
Media@cellular-goods.com (mailto:Media@cellular-goods.com)
Corporate Broker & Advisor
Brian Stockbridge +44 7858 888 007
Novum Securities
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
About Cellular Goods PLC:
Cellular Goods is pioneering the use of lab-based and biosynthetic production
methods for wellness and sustainability solutions. The Company launched with a
focus on efficacy led and science-backed products utilising biosynthetics, and
now employs its expertise across two verticals: premium next-generation
cannabinoid skincare products, and carbon sequestration-as-a-service through
its wholly owned business division, King Tide Carbon, which utilises
biosynthetic algae and seaweed to provide scalable carbon removal. The Company
is incorporated in the UK and listed on the Main Market of the London Stock
Exchange. For more information, visit www.cellular-goods.com
(http://www.cellular-goods.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUPURAGUPCPUR